Tag: anticoagulation therapy

Prefer DOACs Over Aspirin After Ventricular Ablations: STROKE-VT

Catheter ablation has been around a lot longer for ventricular arrhythmia than for atrial fibrillation, but far less is settled about what antithrombotic therapy should...

Prophylactic Anticoagulation Tied to Lower Death Rate in COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Dr Valerie M. Vaughn Prophylactic anticoagulation to prevent venous thromboembolism (VTE)...

Rivaroxaban Cut Recurrent Limb Events in VOYAGER-PAD

After patients with peripheral artery disease undergo lower-extremity revascularization, they are at high risk for major adverse limb events, and new findings from a prespecified...

Researchers Detail More Cases of Clots Tied to COVID Vaccines

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. New evidence emerged today tying vaccines for COVID-19 to extremely rare...

More Evidence Supports Early Anticoagulation in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Early initiation of prophylactic anticoagulation in COVID-19 patients newly admitted to...

Colchicine Reduces Complications in Outpatient COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The oral, anti-inflammatory drug colchicine can prevent complications and hospitalizations in...

Full-Dose Anticoagulation Reduces Need for Life Support in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Full-dose anticoagulation was superior to low, prophylactic doses in reducing the...

PFO Closure Beneficial in Stroke Patients With Thrombophilia

Thrombophilic patients who have had an ischemic stroke and have a patent foramen ovale (PFO) benefit from having the PFO closed, a new study suggests....

Mini-Dose Edoxaban May Safely Cut AF Stroke Risk in Very Elderly

An ultra-low dose of direct oral anticoagulant (DOAC) may safely cut the risk for stroke in very elderly patients with atrial fibrillation (AF) whose bleeding...

New Data on Benefit, Risk for Anticoagulation in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two studies from New York City, the early epicenter of the...

Early Rhythm Control in AF Gains New Life

Initiation of rhythm control with antiarrhythmic drugs and/or ablation in patients with early, recently diagnosed atrial fibrillation led to a significantly lower risk for major...

Finer Risk Stratification Key in Acute Pulmonary Embolism

All intermediate-risk pulmonary embolism is not the same, Victor F. Tapson, MD, declared at the virtual annual conference of the Society of Hospital Medicine. The...

Extended Rivaroxaban in Medical Patients Cuts Arterial Events Too

Extended prophylaxis with a low dose of the anticoagulant rivaroxaban (Xarelto, Janssen) in selected medically ill patients being discharged from hospital reduced both venous and...

DOACs Linked to Lower Fracture Risk vs Warfarin in AFib Patients

Among patients with atrial fibrillation, use of direct oral anticoagulants is linked to lower osteoporotic fracture risk versus warfarin, results of a recent population-based cohort study...

TWILIGHT Outcomes Hold Regardless of Stent Platform

A new TWILIGHT analysis shows similar efficacy among high-risk patients treated with bioabsorbable polymer and durable-polymer stents and a consistent benefit of ticagrelor (Brilinta, Brilique;...

Some Data May Be Worse Than No Data in the COVID Era

What your doctor is reading on Medscape.com: MAY 14, 2020 — I will critique a research letter on anticoagulation in patients with COVID-19 recently published...

Be Wary of New Treatments, HCW Infections

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Evidence Builds Linking Anticoagulation to COVID-19 Survival

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Use of systemic anticoagulation may improve the chance of survival in...

Cautions Raised Against Off-Label DOACs to Clear LV Thrombi

The newer class of oral anticoagulants that have been supplanting the traditional mainstay warfarin for a variety of indications may be inferior for at least...

Finding the Right Balance in COVID-19 Thromboprophylaxis

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. News this week that Broadway star Nick Cordera had one of...

Edoxaban Noninferior to Warfarin After Valve Surgery?

The first randomized trial comparing a direct oral anticoagulant (DOAC) with warfarin after surgical bioprosthetic valve replacement has suggested noninferiority of edoxaban (Savaysa, Daiichi Sankyo)...

Oral Anticoagulants Often Inappropriately Prescribed for HIV Patients on ART

NEW YORK (Reuters Health) – Direct oral anticoagulants (DOACs) are frequently prescribed for individuals on antiretroviral boosters, despite the risk of drug-drug interactions, researchers say....